Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance

Sotera Health (NASDAQ:SHC) issued an update on its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.950-1.010 for the period, compared to the consensus earnings per share estimate of 0.950. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Wall Street Analysts Forecast Growth

SHC has been the subject of several research analyst reports. Piper Sandler reiterated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. The Goldman Sachs Group started coverage on Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. UBS Group set a $19.00 price target on shares of Sotera Health in a report on Wednesday, June 24th. Barclays raised their price objective on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Finally, Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $20.25.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $17.98 on Thursday. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. Sotera Health has a one year low of $11.00 and a one year high of $19.85. The business has a 50-day simple moving average of $17.00 and a 200 day simple moving average of $16.32. The firm has a market capitalization of $5.13 billion, a price-to-earnings ratio of 43.85 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.Sotera Health’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the business earned $0.14 EPS. On average, research analysts anticipate that Sotera Health will post 0.87 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 15.36% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Sotera Health

Hedge funds have recently added to or reduced their stakes in the stock. Empowered Funds LLC raised its stake in shares of Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after buying an additional 43,471 shares during the last quarter. Acadian Asset Management LLC boosted its position in shares of Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after buying an additional 14,018 shares during the last quarter. Creative Planning grew its holdings in Sotera Health by 15.3% during the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after buying an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in Sotera Health by 4.2% during the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after buying an additional 12,758 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.